# Rhinal Therapeutics Inc. — Form D

Rhinal Therapeutics Inc. of LAS VEGAS, NV, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-07. The offering totals $1.0M, of which $20K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-08-07
- Form: D
- Accession: 0002080382-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $20K
- Remaining: $980K
- Investors: 1
- Date of first sale: 2025-07-28
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-554015

## Issuer

- Name: Rhinal Therapeutics Inc.
- CIK: 0002080382
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2023
- Address: 732 S 6TH ST, LAS VEGAS, NV, 89101
- Phone: 7029816980

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Robert Clayborough | Director | Las Vegas, NV |
| Lawrence Fox | Director | New York, NY |
| Mike George | Director | Las Vegas, NV |
| Frank Puglisi | Director | Las Vegas, NV |
| Robert Clayborough | Executive Officer | Las Vegas, NV |
| Lawrence Fox | Executive Officer | New York, NY |
| Austin Panhans | Executive Officer | Las Vegas, NV |
| Frank Puglisi | Executive Officer | Las Vegas, NV |

## More

- [CIK 2080382 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2080382&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002080382-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.